Redcare Pharmacy N.V.
ISIN: NL0012044747
WKN: A2AR94
23 Oktober 2026 10:58AM

EQS-News: How can digitalization improve healthcare?

Redcare Pharmacy N.V. · ISIN: NL0012044747 · EQS - Company News
Land: Niederlande · Primärmarkt: Niederlande · EQS News ID: 2421242

EQS-News: Redcare Pharmacy N.V. / Key word(s): Miscellaneous
How can digitalization improve healthcare?

23.10.2026 / 10:58 CET/CEST
The issuer is solely responsible for the content of this announcement.


Key takeaways from Redcare Pharmacy’s Transformationsdialog.

Sevenum, the Netherlands, October 23, 2026 – How can healthcare in Germany be shaped to meet future challenges while putting patients’ needs at its center? How can digital solutions help not only safeguard healthcare provision but take it to the next level?

These questions were at the heart of Redcare Pharmacy’s Transformationsdialog, hosted by Europe’s leading online pharmacy on October 15, 2026, in Berlin. Representatives from healthcare, politics and business discussed how digital solutions can contribute to better, more reliable and more connected healthcare.

Existing healthcare structures are under considerable pressure and the need for innovative solutions is growing. For Peter Schmid von Linstow, CEO of Redcare Pharmacy, it is therefore clear that the opportunities offered by digital transformation must be fully embraced. Marking the company’s 25th anniversary, he looked ahead: Redcare aims to further expand its role in healthcare in the coming years, harness the potential of digital technologies and artificial intelligence and help take patient care to the next level.

Digital innovation must deliver tangible benefits.

In his keynote, Dr. Gregor-Konstantin Elbel, Partner at the consulting firm Deloitte, outlined possible scenarios for healthcare in 2035. The discussion highlighted that digital technologies can only realize their full potential when digital applications, health data, pharmaceutical expertise and physical healthcare services are meaningfully connected. E-prescriptions are a good example of how this can work: They offer clear benefits and integrate seamlessly into people's everyday lives, encouraging the rapid adoption and acceptance of digital innovations.

Günther Jauch, who serves as the brand ambassador for Shop Apotheke in Germany, was also part of the event. In a conversation with Dr. Susanne Holst, he explained why he chose to partner with Shop Apotheke and shared his perspective on the benefits of digital healthcare solutions. The importance of trust was also a central theme of the discussion.

Connecting pharmaceutical expertise and digital solutions.

During the panel discussion, Theresa Holler, COO and Responsible Pharmacist at Redcare Pharmacy, Dr. Susanne Ozegowski, former Head of the Digitalization and Innovation Department at the German Federal Ministry of Health, and Prof. Dr. David Matusiewicz, Professor of Healthcare Management at FOM University of Applied Sciences, explored what pharmaceutical care could look like in the future.

Digital solutions can make healthcare more accessible, enhance medication safety and provide better support for patients in their everyday lives. Theresa Holler emphasized that Redcare Pharmacy is already making a significant contribution in this area: As an online pharmacy, Redcare combines digital services, such as the convenient redemption of e-prescriptions via its app, with professional pharmaceutical advice from pharmacists and reliable delivery of medicines directly to patients' homes. This is particularly beneficial for people living in rural areas or with limited mobility. However, improving healthcare also requires stronger connections between different stakeholders and services.

The panelists agreed that the future of healthcare is not about choosing between digital and traditional in-person services. Instead, it requires an innovative, complementary system in which different healthcare channels can build on their respective strengths and patients benefit from closer collaboration between providers. The goal is to rethink healthcare as a whole, making it more accessible, improving quality and placing greater emphasis on individual needs.

Creating the right conditions for innovation.

The discussion also highlighted that many innovative approaches have yet to achieve widespread adoption. To unlock the full potential of digital healthcare, reliable regulatory frameworks, greater interoperability between systems and more room for innovation are needed. The objective must be a healthcare system that enables competition while ensuring data exchange and collaboration among different stakeholders.

The Transformationsdialog was held as part of Redcare Pharmacy's 25th anniversary celebrations. With around 15 million active customers, the company is now Europe's leading online pharmacy and a key driver in the continued development of pharmaceutical care.
 

___

About Redcare Pharmacy.

Originally founded in 2001, Redcare Pharmacy N.V., with EUR 2.9B in revenues in 2025, is the leading online pharmacy in Europe and active in seven countries (Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland). Headquartered in the Netherlands, Redcare Pharmacy offers its over 14 million active customers more than 500,000 different healthcare-related products. Besides OTC drugs, nutritional supplements, beauty and personal care products, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands, operating as a true one-stop pharmacy. As the pharmacy of the future, Redcare stands for comprehensive pharmaceutical services for its customers – with pharmaceutical safety always being the top priority.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange, Prime Standard, since 2016 and is part of the SDAX.



23.10.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
LEI Code: 529900JK6UXHY1YKZ082
EQS News ID: 2421242

 
End of News EQS News Service

2421242  23.10.2026 CET/CEST

Zur besseren Einschätzung der fundamentalen Entwicklung der jeweiligen Unternehmen bietet boersengefluester.de (BGFL) eine Übersicht mit den wesentlichen Kennzahlen zu Umsatz, Ergebnis, Cashflow und Dividende. Sämtliche Angaben werden manuell in unserer Datenbank erfasst – Quelle sind die jeweiligen Geschäftsberichte. Sofern es sich um Schätzungen für künftige Zahlen handelt, stammen sie durchweg von BGFL. 

Die wichtigsten Finanzdaten auf einen Blick
  2020 2021 2022 2023 2024 2025 2026e
Umsatzerlöse1 968,06 1.060,32 1.204,35 1.798,76 2.370,58 2.940,90 3.440,00
EBITDA1,2 15,20 -38,73 -29,66 39,99 29,23 47,40 81,00
EBITDA-Marge3 1,57 -3,65 -2,46 2,22 1,23 1,61 2,36
EBIT1,4 -0,87 -65,70 -69,17 -17,30 -38,99 -28,50 9,00
EBIT-Marge5 -0,09 -6,20 -5,74 -0,96 -1,65 -0,97 0,26
Jahresüberschuss1 -16,77 -74,19 -77,65 -11,61 -46,36 -39,40 -15,00
Netto-Marge6 -1,73 -7,00 -6,45 -0,65 -1,96 -1,34 -0,44
Cashflow1,7 17,80 11,64 -29,11 61,46 22,13 31,00 39,00
Ergebnis je Aktie8 -1,17 -4,15 -4,32 -0,73 -2,27 -1,87 -0,73
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben
Legende

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Forvis Mazars

Alle relevanten Bewertungskennzahlen, Termine und sonstige Investor-Informationen zu Ihrer Aktie kompakt zusammengefasst. Gut zu wissen: Sämtliche Daten stammen von boersengefluester.de werden täglich aktualisiert. Damit sind Sie immer auf dem neuen Stand. Kurze Erkärungen zu den Kennzahlen bekommen Sie, wenn Sie mit dem Cursor bzw. der Maus auf das jeweilige Feld gehen.

INVESTOR-INFORMATIONEN
©boersengefluester.de
Redcare Pharmacy
WKN ISIN Rechtsform Börsenwert IPO Einschätzung Plus Code
A2AR94 NL0012044747 N.V. 1.575,28 Mio € 13.10.2016 Halten 9F3893WC+F5
* * *
KGV 2027e KGV 10Y-Ø BGFL-Ratio Shiller-KGV KBV KCV KUV
46,39 0,00 0,00 -40,85 3,43 50,82 0,54
Dividenden
Dividende '2024
in €
Dividende '2025
in €
Dividende '2026e
in €
Div.-Rendite '2026e
in %
0,00 0,00 0,00 0,00%
Finanztermine
Hauptversammlung Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
15.04.2026 06.05.2026 29.07.2026 29.10.2026 04.03.2026
Performance-Angaben
Abstand 60-Tage-Linie Abstand 200-Tage-Linie Performance YtD Kursveränderung 52 Wochen IPO
Akt. Kurs (EoD)
-2,67%
76,55 €
ATH 249,00 €
+18,70% +33,30% +16,25% -4,43% +173,39%

Werbung ist für uns ein wichtiger Einnahmekanal. Aber wir verstehen, dass sie manchmal lästig wird. Wenn Sie die Anzahl der angezeigten Werbung reduzieren möchten, loggen Sie sich einfach in Ihr Benutzerkonto ein und verwalten Sie die Einstellungen von dort aus. Als registrierter Benutzer erhalten Sie viele Vorteile.
          Qualitätsjournalismus · 2013-2026 · Made in Germany          
Die Analyse-Manufaktur

Informierte Anleger treffen bessere Entscheidungen

Auf dem 2013 von Gereon Kruse gegründeten Finanzportal boersengefluester.de dreht sich alles um deutsche Aktien – mit klarem Schwerpunkt auf Nebenwerte. Neben klassischen redaktionellen Beiträgen sticht die Seite insbesondere durch eine Vielzahl an selbst entwickelten Analysetools hervor. Basis sämtlicher Tools ist eine komplett selbst gepflegte Datenbank für mehr als 650 Aktien. Damit erstellt boersengefluester.de Deutschlands größte Gewinn- und Dividendenprognose.

Kontakt

Idee & Konzept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 von Gereon Kruse #BGFL